These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 18547617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder.
    Shariat SF, Kim JH, Ayala GE, Kho K, Wheeler TM, Lerner SP.
    J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
    Horikawa Y, Sugano K, Shigyo M, Yamamoto H, Nakazono M, Fujimoto H, Kanai Y, Hirohashi S, Kakizoe T, Habuchi T, Kato T.
    J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
    [Abstract] [Full Text] [Related]

  • 6. A mapping of histology and cell proliferation in human bladder cancer: an immunohistochemical study.
    Igawa M, Urakami S, Shirakawa H, Shiina H, Ishibe T, Usui T, Moriyama H.
    Hiroshima J Med Sci; 1995 Dec; 44(4):93-7. PubMed ID: 8857231
    [Abstract] [Full Text] [Related]

  • 7. [A case report: small cell carcinoma transformed from transitional cell carcinoma of the urinary bladder].
    Hirayama T, Matsumoto K, Kurosaka S, Muramoto M, Irie A, Iwamura M, Baba S, Uchida T, Ichinohe M, Iwabuchi K.
    Hinyokika Kiyo; 2006 Aug; 52(8):633-5. PubMed ID: 16972627
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Two molecular pathways to transitional cell carcinoma of the bladder.
    Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R.
    Cancer Res; 1994 Feb 01; 54(3):784-8. PubMed ID: 8306342
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT, Pak J, Shapiro E, Sun TT, Wu XR.
    Cancer Res; 1999 Jul 15; 59(14):3512-7. PubMed ID: 10416618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair.
    Blanes A, Rubio J, Sanchez-Carrillo JJ, Diaz-Cano SJ.
    Hum Pathol; 2009 Jul 15; 40(7):988-97. PubMed ID: 19368958
    [Abstract] [Full Text] [Related]

  • 18. Autopsy case of primary small cell carcinoma of the urinary bladder: KIT and PDGFRA expression and mutations.
    Terada T.
    Pathol Int; 2009 Apr 15; 59(4):247-50. PubMed ID: 19351368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.